Davos WEF
Davos WEF

ECB's Lagarde says pandemic recovery might be delayed, but shouldn't be derailed

Key Points
  • The euro zone is grappling with surging coronavirus cases, tough social restrictions and a slow rollout of vaccines.
  • According to Lagarde, the current economic environment "is still about crossing that bridge to the recovery, but where the journey seems to be little bit delayed, but should not be derailed."
Economic recovery has been 'delayed, not derailed,' ECB's Lagarde says
VIDEO0:0000:00
Economic recovery has been 'delayed, not derailed,' ECB's Lagarde says

LONDON — European Central Bank President Christine Lagarde hopes that 2021 will still be the year of economic recovery post-pandemic, despite strict lockdowns and concerns over new Covid-19 variants.

"Our hope is that still 2021 is the year of recovery but in two phases and phase one is clearly one that it is still plagued with very high level of uncertainty," Lagarde said at a CNBC-moderated panel at the Davos Agenda summit on Monday.

The euro zone is grappling with surging coronavirus cases, tough social restrictions and a slow rollout of vaccines. This is creating further economic pain for the region, which is estimated to have contracted more than 7% in 2020.

According to Lagarde, the current economic environment "is still about crossing that bridge to the recovery, but where the journey seems to be a little bit delayed, but should not be derailed."

The euro zone entered the new year facing a stepping up of coronavirus restrictions: France intensified its curfew hours, Germany extended its national lockdown until mid-February, the Netherlands also announced a new curfew and other countries decided to close schools.

The latest variants of Covid-19 are a concern for policymakers as these have contributed to higher numbers of daily infections — in some cases worse than during the first wave of cases in the spring of 2020.

It is not the same economy.
Christine Lagarde
ECB president

European countries started vaccinating citizens in late December but the rollout has been criticized for being too slow. In the latest escalation, the European Commission, the institution negotiating vaccine contracts on behalf of the 27 EU governments, confronted AstraZeneca on Monday for its delay in delivering its vaccines.

The pharmaceutical giant, whose vaccine could receive approval in the EU later this week, had informed the Commission on Friday that it will be delivering fewer doses in the coming weeks. This could become another headache for European governments looking to step up the number of daily vaccinations.

European Central Bank (ECB) President Christine Lagarde gestures as she addresses a news conference on the outcome of the meeting of the Governing Council, in Frankfurt, Germany, March 12, 2020.
Kai Pfaffenbach | Reuters

Stimulus remains

The latest ECB economic data points to a contraction in the final quarter of 2020, which, according to Lagarde "will have an impact in the first quarter of 2021."

In December, the ECB estimated a 3.9% GDP rate for 2021, and 2.1% for 2022, but these forecasts are heavily dependent on how the pandemic evolves and how fast citizens can be vaccinated.

Even when the European region reaches a point when its economies are able to reopen fully, there will be further challenges to ensure there's solid economic growth. "It is not the same economy that we are talking about," Lagarde added.

The ECB decided last week to keep its vast monetary stimulus unchanged. Its Pandemic Emergency Purchase Program, which could last until March 2022, could buy as much as 1.85 trillion euros ($2.25 trillion) in bonds. This exercise is helping to keep borrowing costs lower for euro zone governments. The central bank's interest rates also remain at historic lows to further boost lending in the region.